The purpose of the study is to recognize main causes of acute decompensation of chronic congestive heart failure.
- Study Type: Observational
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: February 2012
Congestive heart failure (CHF) presents a very significant cause of morbidity and mortality. The prevalence of CHF is between 2 and 4% and rises with age (in 70- to 80-year-old people is between 10 and 20%). CHF is the cause of 5% of all acute hospital admissions and accounts for 2% of expenses on health. The most common causes of worsening of the chronic CHF are ischemia, arrhythmias, valvular dysfunction, systemic or pulmonary hypertension, volume overload or fluid retention, high output conditions (infection, anemia, thyrotoxicosis), drugs (NSAIDs, cyclo-oxygenase (COX) inhibitors, thiazolidinediones) and medication nonadherence. The goal of this study is to determine the proportion of various reasons of acute worsening of CHF, using commonly available methods including assessment of serum drug levels.
Arms, Groups and Cohorts
- Congestive heart failure
- Patients suffering from sudden worsening of congestive heart failure
Participating in This Clinical Trial
- able to provide informed consent – aged 19 years or more – history of heart failure of at least one month – examined or hospitalized for acute dyspnea at rest or with minimal exertion – clinical signs of fluid overload defined as at least one of following: – rales – jugular venous distension – peripheral edema – pulmonary congestion on X-ray – NT-proBNP above 210 pmo/l Exclusion Criteria:
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- University Hospital Hradec Kralove
- Provider of Information About this Clinical Study
- Pelouch Radek, MD, University Hospital Hradec Kralove
- Overall Official(s)
- Radek Pelouch, MD, Principal Investigator, University Hospital Hradec Kralove
- Overall Contact(s)
- Radek Pelouch, MD, 00420495834740, email@example.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.